5 Steps to prevent Heart Disease

Friday, October 30, 2015

New Research on Niacin 2015

           New Research on Niacin 2015 link

Conclusions—
 In statin-treated men with type 2 diabetes mellitus, Extended Release Niacin decreased plasma Lp(a) concentrations by decreasing the production of apo(a) and Lp(a)-apoB-100. 

Extended Release Niacin also decreased the concentrations of apoB-100–containing lipoproteins by decreasing VLDL production and the transport of these particles down the VLDL to LDL cascade.

 Our study provides further mechanistic insights into the lipid-regulating effects of Extended Release Niacin. 


No comments:

Post a Comment